120 related articles for article (PubMed ID: 38840775)
1. Ketamine modulates disrupted in schizophrenia-1/glycogen synthase kinase-3β interaction.
Liu JR; Han XH; Yuki K; Soriano SG
Front Mol Neurosci; 2024; 17():1342233. PubMed ID: 38840775
[TBL] [Abstract][Full Text] [Related]
2. Role of glycogen synthase kinase-3β in ketamine-induced developmental neuroapoptosis in rats.
Liu JR; Baek C; Han XH; Shoureshi P; Soriano SG
Br J Anaesth; 2013 Jun; 110 Suppl 1():i3-9. PubMed ID: 23533250
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Glycogen Synthase Kinase-3β in D
Li YC; Panikker P; Xing B; Yang SS; Alexandropoulos C; McEachern EP; Akumuo R; Zhao E; Gulchina Y; Pletnikov MV; Urs NM; Caron MG; Elefant F; Gao WJ
Biol Psychiatry; 2020 Apr; 87(8):745-755. PubMed ID: 31892408
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of GSK-3beta Signaling Pathway Rescues Ketamine-Induced Neurotoxicity in Neural Stem Cell-Derived Neurons.
Zhang J; Cui C; Li Y; Xu H
Neuromolecular Med; 2018 Mar; 20(1):54-62. PubMed ID: 29218434
[TBL] [Abstract][Full Text] [Related]
5. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
Costemale-Lacoste JF; Guilloux JP; Gaillard R
Encephale; 2016 Apr; 42(2):156-64. PubMed ID: 26995153
[TBL] [Abstract][Full Text] [Related]
6. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
7. The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats.
Huang X; Huang K; Zheng W; Beveridge TJ; Yang S; Li X; Li P; Zhou W; Liu Y
Drug Alcohol Depend; 2015 Feb; 147():257-65. PubMed ID: 25497591
[TBL] [Abstract][Full Text] [Related]
8. The potential role of GSK-3β signaling pathway for amelioration actions of ketamine on the PTSD rodent model.
Hu X; Liu L; Wang Z; Sun Y; Li Z; Zhou G; Yue K; Wang L; Lian B; Lu G; Li C; Sun L
Brain Res Bull; 2023 Aug; 200():110697. PubMed ID: 37392896
[TBL] [Abstract][Full Text] [Related]
9. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
[TBL] [Abstract][Full Text] [Related]
10. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
11. Lithium protection of phencyclidine-induced neurotoxicity in developing brain: the role of phosphatidylinositol-3 kinase/Akt and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling pathways.
Xia Y; Wang CZ; Liu J; Anastasio NC; Johnson KM
J Pharmacol Exp Ther; 2008 Sep; 326(3):838-48. PubMed ID: 18544676
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium.
Lucas FR; Goold RG; Gordon-Weeks PR; Salinas PC
J Cell Sci; 1998 May; 111 ( Pt 10)():1351-61. PubMed ID: 9570753
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3β signaling pathways.
Jin Y; Sui HJ; Dong Y; Ding Q; Qu WH; Yu SX; Jin YX
Acta Pharmacol Sin; 2012 Jul; 33(7):861-72. PubMed ID: 22705730
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Protects Neural Stem Cells from Ketamine-Induced Injury.
Lu P; Lei S; Li W; Lu Y; Zheng J; Wang N; Xia Y; Lu H; Chen X; Liu Y; Zhang PB
Cell Physiol Biochem; 2018; 47(4):1377-1388. PubMed ID: 29929189
[TBL] [Abstract][Full Text] [Related]
15. Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model.
Pogorelov VM; Nomura J; Kim J; Kannan G; Ayhan Y; Yang C; Taniguchi Y; Abazyan B; Valentine H; Krasnova IN; Kamiya A; Cadet JL; Wong DF; Pletnikov MV
Neuropharmacology; 2012 Mar; 62(3):1242-51. PubMed ID: 21315744
[TBL] [Abstract][Full Text] [Related]
16. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity.
Yoshimura T; Kawano Y; Arimura N; Kawabata S; Kikuchi A; Kaibuchi K
Cell; 2005 Jan; 120(1):137-49. PubMed ID: 15652488
[TBL] [Abstract][Full Text] [Related]
17. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
Elyaman W; Terro F; Wong NS; Hugon J
Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
[TBL] [Abstract][Full Text] [Related]
19. The role of Akt-GSK-3beta signaling and synaptic strength in phencyclidine-induced neurodegeneration.
Lei G; Xia Y; Johnson KM
Neuropsychopharmacology; 2008 May; 33(6):1343-53. PubMed ID: 17637606
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
